Drug Profile
Mitumomab
Alternative Names: Anti-idiotype cancer vaccine - ImClone Systems/Merck KGaA; BEC-2; IMC-BEC2; LuVax; MelVax; Monoclonal antibody BEC-2Latest Information Update: 24 Oct 2021
Price :
$50
*
At a glance
- Originator ImClone Systems
- Class Cancer vaccines; Monoclonal antibodies
- Mechanism of Action Antibody-dependent cell cytotoxicity; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Malignant melanoma; Small cell lung cancer
Most Recent Events
- 13 Jun 2005 Discontinued - Phase-II for Malignant melanoma in USA (unspecified route)
- 13 Jun 2005 Discontinued - Phase-III for Small cell lung cancer in Australia (unspecified route)
- 13 Jun 2005 Discontinued - Phase-III for Small cell lung cancer in Canada (unspecified route)